In a report published Thursday, Stifel analyst Annabel Samimy reiterated a Buy rating on Perrigo Company PRGO, and raised the price target from $150.00 to $165.00.
In the report, Stifel noted, “PRGO shares have appreciated nearly 30% since late August, after pulling back following transaction announcement. This compares to +10% for S&P 500 during the same period. That said, we maintain our Buy rating on PRGO and raise our target price to $165. We think long-term growth prospects for PRGO remains very attractive, benefiting from 1) favorable macroeconomic trends, 2) important healthcare tailwinds, 3) continued shift to store brand, 4) operating leverage and 5) a flexible financial structure that includes a tax platform for future M&A. We believe PRGO is well position for continued organic growth, and expect opportunity for realized Elan acquisition accretion through the second half FY2014 from a low-risk, passive royalty stream, tax compression, and flexibility for addition bolt-on transactions through the new Irish platform.”
Perrigo Company closed on Wednesday at $151.11.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in